Brian Joondeph, MD
Retina Specialist · Denver, CONPI 1932151230
Payments from drug & device makers
Across 307 payments — averaging $5058.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1.4M
- Astellas Pharma Global Development$39K
- Eyepoint US, Inc.$26K
- AbbVie$25K
- US Retina LLC$20K
- Biogen$15K
- plus $7K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 47 | $1,420,770 |
| Astellas Pharma Global Development | 17 | $39,342 |
| Eyepoint US, Inc. | 9 | $25,939 |
| AbbVie(2 entities) | 70 | $25,427 |
| US Retina LLC | 15 | $20,042 |
| Biogen | 23 | $14,803 |
| Vertex | 3 | $1,207 |
| Alcon | 4 | $1,042 |
| Regeneron Healthcare Solutions, Inc. | 33 | $1,025 |
| Genentech, Inc. | 5 | $746 |
| Genentech USA, Inc. | 27 | $523 |
| Astellas Pharma US Inc | 12 | $517 |
| Alimera Sciences, Inc. | 7 | $366 |
| Coherus Oncology, Inc. | 9 | $220 |
| Cardinal Health 110 LLC | 1 | $150 |
| Apellis Pharmaceuticals, Inc. | 6 | $147 |
| Regeneron | 1 | $134 |
| Bausch & Lomb Americas Inc. | 5 | $122 |
| Topcon Healthcare, Inc. | 1 | $104 |
| ANI Pharmaceuticals, Inc. | 4 | $92 |
| Optos, Inc. | 1 | $86 |
| Heidelberg Engineering, Inc. | 1 | $76 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $75 |
| Harrow Eye, LLC | 3 | $63 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Carl Zeiss Meditec AG | 1 | $19 |
How this compares
$1,553,073 in reported general payments places this provider in the 90th percentile of 51 retina specialist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Denver
- Nancy ChristmasDenver$775K
- Alan KimuraDenver$546K
- Jesse SmithDenver$23K
- Miriah TeeterDenver$3K
- Diana ReevesDenver$3K
- Mariana HarasawaDenver$332
- Sara HaugDurango$9.5M
- James LuuColorado Springs$2.9M
- Mimi LiuEnglewood$2.2M
- Murtaza AdamParker$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.